Welcome to LookChem.com Sign In|Join Free
  • or
Antimex Chemical LimiedGanciclovir//file1.lookchem.com/cas/reactions/2021/06/01/3654487.png

Communicate with Supplier:

Mr. Tony
Mr. Tony: What can I do for you?

Ganciclovir CAS NO.82410-32-0

Min.Order Quantity:
0 Metric Ton
Purity:
98.0%min
Port:
Shanghai
Payment Terms:
D/A,T/T

Add to Inquiry Cart

Product Details

Keywords

  • Ganciclovir manufacture
  • 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
  • CAS : 82410-32-0

Quick Details

  • ProName: Ganciclovir
  • CasNo: 82410-32-0
  • Molecular Formula: C?H??N?O?
  • Appearance: White crystal powder
  • Application: Ganciclovir is a nucleoside analog st...
  • DeliveryTime: 10days
  • PackAge: 25kgs/drum
  • Port: Shanghai
  • ProductionCapacity: Metric Ton/Day
  • Purity: 98.0%min
  • Transportation: By air or by sea
  • LimitNum: 0 Metric Ton

Superiority

ganciclovir (ganciclovir), the chemical name 9- (1, 3-dihydroxy-2-propoxymethyl) guanine, belongs to the nucleoside antiviral drugs, being a kind of guanosine derivatives. it has broad-spectrum, high-efficient inhibitory effects on herpes virus and is the first-choice drug for the treatment of cytomegalovirus infection with strong effect on hepatitis b virus and adenovirus as well. it is homologue of acyclovir (acv) with its antiviral effect being similar as, but stronger than aciclovir, having especially strong inhibitory effects on cytomegalovirus associated with aids patients.

Details

1. induction and maintenance treatment of cmv retinitis in immunocompromised patients (including aids patients).
2. prevention of cytomegalovirus infection in patients receiving organ transplants and prophylaxis of cytomegalovirus disease in hiv-positive patients with cytomegalovirus seroprevalence.
for immunodeficient patients with life-threatening or vision-related cytomegalovirus (cmv) infections, such as aids, exogenous immunosuppressive patients associated with organ transplantation and tumor chemotherapy.
antiviral drugs, for the treatment of cytomegalovirus (cmv) infections caused by low immune capability.
for antiviral drugs intermediates
1. induction and maintenance treatment of cmv retinitis in immunocompromised patients (including aids patients).
2. prevention of cytomegalovirus infection in patients receiving organ transplants and prophylaxis of cytomegalovirus disease in hiv-positive patients with cytomegalovirus seroprevalence.
for immunodeficient patients with life-threatening or vision-related cytomegalovirus (cmv) infections, such as aids, exogenous immunosuppressive patients associated with organ transplantation and tumor chemotherapy.
antiviral drugs, for the treatment of cytomegalovirus (cmv) infections caused by low immune capability.
for antiviral drugs intermediates

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)